New topical hair loss treatment shows a 539% improvement in trials, offering hope for male-pattern baldness sufferers after ...

Clascoterone will be the first ever drug in 30 years to treat male pattern baldness by boosting hair growth by 500% ...

The promising results are expected to fetch the FDA approval next year, which would mean that clascoterone will be the first ...

Cosmo Pharmaceuticals says its Phase 3 trials of topical clascoterone for male-pattern hair loss showed statistically ...

Men confronting a receding hairline traditionally have had few choices. Minoxidil and finasteride, the stalwarts of hair-loss treatment, arrived in the 1980s and 1990s. Since then, little has changed.

An acne drug, clascoterone, has demonstrated remarkable results in treating male pattern baldness. In two large Phase III ...

In a trial, clascoterone showed a whopping 539 percent relative improvement in hair count compared to the placebo.

A new topical treatment, Clascoterone, shows significant promise for male pattern baldness, offering a novel approach beyond ...

Male pattern baldness, also known as androgenic alopecia, is a widespread form of hair loss that affects men, often beginning ...

Scientists may have found a cure for male-pattern baldness, and it isn't a box of Rogaine. According to a new study, scientists were able to regrow hair on a mouse much faster than leading treatments.

Minoxidil is an established, first-line treatment for hair loss. There is less evidence to support the efficacy of hair loss ...

A common acne medicine may soon change the future of hair loss treatment. New research shows clascoterone could become the ...